Urate predicts subsequent cardiac death in stroke survivors

European Heart Journal

Volumn 23, Issue 10, 2002, Pages 788-793

  Wong, K Y K ^a,b   Macwalter, R S ^a   Fraser, H W ^a   Crombie, I ^a   Ogston, S A ^a   Struthers, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Cardiac death; Stroke; Urate

Indexed keywords

CHOLESTEROL; CREATININE; DIURETIC AGENT; GLUCOSE; URATE;

AGED; ARTICLE; BLOOD LEVEL; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STROKE; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCOTLAND; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVORS; URIC ACID;

EID: 0036558521     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2970     Document Type: Article

References (31)

1. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: The Oxfordshire Community Stroke Project. Stroke 1993; 24: 796-800.
2. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [published errata appear in N Engl J Med 2000 Mar 9;342(10):748 and 2000 May 4;342(18):1376]. N Engl J Med 2000; 342: 145-53.
3. Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet 1999; 354: 1578.
4. Kohn PM, Prozan GB. Hyperuricaemia: relationship to hypercholesterolaemia and acute myocardial infarction. JAMA 1959; 170: 1909-15.
5. Beard JT. Serum uric acid and coronary heart disease. Am Heart J 1983; 106: 397-400.
6. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999; 10: 391-7.
7. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29: 635-9.
8. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
9. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997; 78: 147-53.
10. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999; 100: 354-60.
11. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11·5-year mortality of middle-aged women: Findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989; 42: 257-67.
12. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension [published erratum appears in Lancet 1998 Sep 12;352(9131):912]. Lancet 1998; 352: 670-1.
13. Castelli P, Condemi AM, Brambillasca C et al. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol 1995; 25: 119-25.
14. De Scheerder IK, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation. Am J Cardiol 1991; 68: 392-5.
15. Muscelli E, Natali A, Bianchi S et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996; 9: 746-52.
16. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995; 310: 560-4.
17. Selby JV, Friedman GD, Quesenberry CP, Jr. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries [published erratum appears in Am J Epidemiol 1990 Sep; 132(3):589]. Am J Epidemiol 1990; 131: 1017-27.
18. Waring WS, Webb DJ, Maxwell SRJ. Effect of local hyperuricaemia on endothelial function in the human forearm vascular bed. Br J Clin Pharmacol 2000; 49: 511P.
19. Britten MB, Eisner M, Walter DH, Schachinger V. Elevated uric acid levels in hypercholesterolaemia are associated with coronary endothelial dysfunction (Abstr). Circulation 1999; 100 (Suppl I): 6 (abstract no. 31).
20. Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: A study using uric acid. Biochem J 1999; 340 (Pt 1): 143-52.
21. Boogaerts MA, Hammerschmidt DE, Roelant C, Verwilghen RL, Jacob HS. Mechanisms of vascular damage in gout and oxalosis: Crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 1983; 50: 576-80.
22. Duff GW, Atkins E, Malawista SE. The fever of gout: Urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians 1983; 96: 234-45.
23. Hutton CW, Collins AJ, Chambers RE, Whicher J, Dieppe PA. Systemic response to local urate crystal induced inflammation in man: A possible model to study the acute phase response. Ann Rheum Dis 1985; 44: 533-6.
24. Leyva F, Anker SD, Godsland IF et al. Uric acid in chronic heart failure: A marker of chronic inflammation. Eur Heart J 1998; 19: 1814-22.
25. Falasca GF, Ramachandrula A, Kelley KA, O'Connor CR, Reginato AJ. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 1993; 36: 105-16.
26. Waring WS, Webb DJ, Maxwell SRJ. Uric acid as a risk factor for cardiovascular disease. Q J Med 2000; 93: 707-13.
27. Patetsios P, Rodino W, Wisselink W, Bryan D, Kirwin JD, Panetta TF. Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann NY Acad Sci 1996; 800: 243-5.
28. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-51.
29. Cardillo C, Kilcoyne CM, Cannon RO, III, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; 30: 57-63.
30. Farquharson C, Butler RA, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. J Am Coll Cardiol 1999; 33 (Suppl A): 216A.
31. Pan WH, Chin CJ, Sheu CT, Lee MH. Hemostatic factors and blood lipids in young Buddhist vegetarians and omnivores. Am J Clin Nutr 1993: 58: 354-9.